Paratek Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Paratek Pharmaceuticals Inc
CIK #0001037643, 0001178711
EDGAR Form CIK 2011 - 2026
D [0001037643]
SC 13D [0001037643]
10-K [0001178711]
10-Q [0001178711]
3 [0001178711]
4 [0001178711]
8-K [0001178711]
SC 13D [0001178711]
SC 13G [0001178711]
Form 13D/13G Filer Form 13D/13G Subject Filed
Continental General Insurance Co Paratek Pharmaceuticals Inc [2023-09-05]
NexPoint Real Estate Opportunities LLC Paratek Pharmaceuticals Inc [2023-03-30]
NexPoint Real Estate Opportunities LLC Paratek Pharmaceuticals Inc [2023-03-27]
BlackRock Inc Paratek Pharmaceuticals Inc [2022-07-08]
Lytton Laurence W Paratek Pharmaceuticals Inc [2022-05-18]
Dondero James D Paratek Pharmaceuticals Inc [2022-03-11]
Hirschman Orin Paratek Pharmaceuticals Inc [2022-03-09]
Highland Capital Management Fund Advisors LP Paratek Pharmaceuticals Inc [2021-02-12]
UBS Group AG Paratek Pharmaceuticals Inc [2019-02-15]
Highland Capital Management LP Paratek Pharmaceuticals Inc [2019-02-14]
View All
Form 3/4/5 Subject 2011 - 2026
Transcept Pharmaceuticals Inc
Franson Timothy R
Woodrow Adam
Loh Evan
Dietz Thomas John
Radie Robert S
Bigham Michael
Haskel William M
Stein Jeffrey
Peterson Kristine
Brenner Randall B
Hoffmann Rolf K
Baylor-Henry Minnie
Dondero James D
Pagan Douglas W
Omega Fund IV LP
Omega Fund III LP
Lim Richard J
HBM BioVentures Cayman Ltd
Danish BioVenture General Partner ApS
K/S Danish BioVenture
Omega Fund III GP LP
Stampacchia Otello
Omega Fund Management LTD
Omega Fund IV GP LP
Omega Fund IV GP Manager Ltd
Omega Fund III GP Ltd
Sigma Holding LTD
Boxmeyer Kathryn M
Kiley Thomas
Oclassen Glenn A
Kollins John A
Patterson Leone D
Nunn Jason Raleigh
Singh Nikhilesh N
Raab G Kirk
Ruegsegger Frederick J
LOAR Matthew M
Roumell Asset Management LLC
Soloway Thomas P
Ehrlich Christopher B
Wortzman Marilyn E
Laporte Kathleen
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
2023-09-21 Disposed to issuer 12,800
Transcept Pharmaceuticals Inc PRTK
Common Stock
2023-09-21 Disposed to issuer 59,000
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
2023-09-21 Disposed to issuer 10,000
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
2023-09-21 Disposed to issuer 6,000
Transcept Pharmaceuticals Inc PRTK
Common Stock
2023-09-21 Disposed to issuer 126,750
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
2023-09-21 Disposed to issuer 7,000
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
2023-09-21 Disposed to issuer 5,000
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
2023-09-21 Disposed to issuer 12,000
Transcept Pharmaceuticals Inc PRTK
Common Stock
2023-09-21 Disposed to issuer 622,284
Transcept Pharmaceuticals Inc PRTK
Common Stock
2023-09-21 Disposed to issuer 48,625
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
2023-09-21 Disposed to issuer 6,000
Transcept Pharmaceuticals Inc PRTK
Common Stock
2023-09-21 Disposed to issuer 89,250
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
2023-09-21 Disposed to issuer 20,000
Transcept Pharmaceuticals Inc PRTK
Common Stock
2023-09-21 Disposed to issuer 26,400
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
2023-09-21 Disposed to issuer 5,000
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
2023-09-21 Disposed to issuer 6,000
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
2023-09-21 Disposed to issuer 20,000
Transcept Pharmaceuticals Inc PRTK
Common Stock
2023-09-21 Disposed to issuer 20,000
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
2023-09-21 Disposed to issuer 7,000
Transcept Pharmaceuticals Inc PRTK
Common Stock
2023-09-21 Disposed to issuer 49,250
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com